GentiBio

GentiBio

Biotechnology Cambridge, Massachusetts, United States 52 employees
Employees
52
Contacts
3
Emails
3
Phones
1

GentiBio Overview

Headquarters
Cambridge, Massachusetts, United States
Industry
Biotechnology
Employees
52
Founded
2020
Funding
157.0M
Company Email
Available in AeroLeads
Keywords

About GentiBio

GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.

GentiBio Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

GentiBio Org Chart

Sample employees and titles
Name Title Contact
Andy Walker President and Chief Executive Officer
Email Phone
Tom Crevier Senior Director, Automation
View
John Wesner Director, Process Development
Email
Nishat Shaikh
Email

Employees by Management Level

Senior / Lead 4 profiles
Director 3 profiles
Individual contributor 3 profiles
Manager 2 profiles
Executive 1 profile
VP / Head 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 5 5 1
IT 2 2 1

GentiBio Tech Stack

Data / AI 6 profiles
Engineering 1 profile

Compare Similar Companies to GentiBio